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OBJECTIVE: As a lifestyle-related disease, social and cultural disparities may influence the features of squamous
cell carcinoma of the head and neck in different geographic regions. We describe demographic, clinical, and
pathological aspects of squamous cell carcinoma of the head and neck according to the smoking and alcohol
consumption habits of patients in a Brazilian cohort.
METHODS: We prospectively analyzed the smoking and alcohol consumption habits of 1,633 patients enrolled
in five Sa˜o Paulo hospitals that participated in the Brazilian Head and Neck Genome Project – Gencapo.
RESULTS: The patients who smoked and drank were younger, and those who smoked were leaner than the
other patients, regardless of alcohol consumption. The non-smokers/non-drinkers were typically elderly white
females who had more differentiated oral cavity cancers and fewer first-degree relatives who smoked. The
patients who drank presented significantly more frequent nodal metastasis, and those who smoked presented
less-differentiated tumors.
CONCLUSIONS: The patients with squamous cell carcinoma of the head and neck demonstrated demographic,
clinical, and pathological features that were markedly different according to their smoking and drinking habits.
A subset of elderly females who had oral cavity cancer and had never smoked or consumed alcohol was notable.
Alcohol consumption seemed to be related to nodal metastasis, whereas smoking correlated with the degree of
differentiation.
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& INTRODUCTION
Squamous cell carcinoma of the head and neck (SCCHN)
is a major health problem worldwide. More than 630,000
new cases and 350,000 deaths were expected to occur in
2008 (1). SCCHN comprises a clinically heterogeneous
group of disorders because presentation, treatment, and
prognosis vary widely according to the tumor site and
clinical stage (2). Tobacco and alcohol are the major risk
factors for its occurrence, but human papillomavirus (HPV)
infection has been shown to be an increasingly important
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risk factor, predominantly in non-smoker/non-drinker
(NSND) patients (3). As a lifestyle pattern-related disease,
social and cultural disparities are expected to influence the
incidence and clinical features in different geographic
regions. This knowledge may be useful in establishing
possible carcinogenic mechanisms and improving the
development of public healthcare policies.
We describe the demographic, clinical, and pathological
aspects of SCCHN according to the smoking and drinking
habits of patients in a Brazilian cohort.
& MATERIALS AND METHODS
Study Design: A cross-sectional observational study of the
demographic, clinical, and pathological features of patients
with SCCHN according to their smoking and drinking
habits.
The patients studied were enrolled from January 2001 to
February 2009 in the head and neck surgery departments of
five hospitals of the Brazilian Head and Neck Genome
Project, Gencapo, a collaborative consortium of research
groups from hospitals and universities in the state of Sa˜o
Paulo, Brazil. The aim of the project is to develop clinical,
genetic, and epidemiological analyses of head and neck
squamous cell carcinomas. We selected patients with oral
cavity (lips excluded), oropharynx, larynx, and hypophar-
ynx squamous cell carcinomas that were confirmed by
histology. The demographic and social information was
prospectively collected by trained interviewers. The clinical
and pathological data were prospectively collected by
assistant clinicians using standardized forms.
The patients were considered to be smokers if they had
smoked at least one cigarette, cigar, or pipe daily for at least
one year during their lifetime and were classified as
drinkers if they had consumed alcoholic beverages at least
once a month on a regular basis. The patients were classified
into four categories: non-smokers/non-drinkers (NSND);
smokers/drinkers (SD); smokers-only (SND); and drinkers-
only (NSD).
The data regarding gender, age, ethnicity, and body mass
index (BMI) were analyzed. Familial cancer history was
calculated by dividing the number of first-degree relatives
with cancer by the total number of first-degree relatives. We
collected data on the number of first-degree relatives who
smoked as an estimated measure of home exposure to
environmental tobacco smoke.
The tumor site, stage, and pathology were analyzed. The
stage classification was performed according to the 5th
(until 2002) and 6th editions (since 2003) of the American
Joint Committee on Cancer (AJCC) TNM classification (4,5).
The pathological aspects analyzed were the tumor variants,
differentiation grade, vascular/lymphatic/perineural inva-
sions, and peritumoral inflammatory infiltrate.
Statistical analysis
For the continuous variables, the means and standard
deviations were calculated. The frequencies and percen-
tages are shown for the categorical variables. Associations
among the categorical variables were analyzed using
Pearson’s chi-square test. For the mean comparisons, we
used one-way ANOVA followed by Tukey’s test to detect
the means that were significantly different.
Ethics
The patients provided informed consent approved by the
ethics committee of each hospital and by the National
Committee on Ethics in Research/CONEP.
& RESULTS
A total of 1,659 patients with SCCHN in selected sites
were identified. Twenty-six patients were excluded for
incomplete data regarding smoking and alcohol consump-
tion. From the remaining 1,633 patients, 80 were NSND
(4.9%), 1,374 were SD (84.1%), 140 were SND (8.6%), and 39
were NSD (2.4%). The distributions according to age,
gender, and site for each group are shown in Figure 1.
The patients in the NSND, SD, SND, and NSD groups
differed in gender, age, ethnicity, mean BMI, and mean
number of first-degree relatives who smoked (Table 1). In an
analysis of the groups, we found that the SD patients had a
mean age of 57 years, whereas the mean age was 62 in the
NSND, SND, and NSD groups. The patients who smoked
(SD and SND) had a mean BMI of 24, whereas the NSND
and NSD patients had a mean BMI of approximately 26. The
NSND patients had fewer relatives who smoked than did
the patients who smoked.
We identified differences among the groups according to
site distribution, clinical/pathological stage, presence of
clinical/pathological node metastasis, differentiation grade,
and lymphatic invasion by histology (Tables 2 and 3).
The categorical variables that showed significant differ-
ences among the groups were analyzed by group (Table 4).
The gender distribution was different in all groups. Female
patients composed a substantial majority of the NSND
patients, approximately one half of the SND group, less than
one-third of the NSD group, and 7% of the SD patients. The
SD patients differed from the other groups according to
ethnicity and had a smaller percentage of whites. The NSND
patients had more oral cavity tumors and fewer larynx
tumors than the other groups, whereas the SND group had
more larynx tumors. Regarding clinical/pathological node
metastasis and lymphatic invasion shown by histology, the
SD patients were more affected than the patients who did not
drink (NSND and SND). The NSD group seemed to be more
affected than the other groups, but the result was not
statistically different, possibly due to the small number of
patients in the group. The SD patients presented at late
pathological stages compared to the NSND and SND
patients. The NSND patients had more differentiated tumors
as shown by histology than the SND and SD patients.
In the analysis by tumor site, we identified significant
differences in relation to the distribution of smoking and
drinking habits. The most remarkable differences observed
included a greater proportion of SND patients among those
with larynx tumors and a greater proportion of NSND
patients among those with oral cavity tumors (Figure 2)
compared with the other groups.
& DISCUSSION
SCCHN is a major cause of cancer morbidity and
mortality in Brazil because the majority of cases are
diagnosed at a late stage (6,7). Although smoking rates are
decreasing, smoking is observed more frequently in
individuals who are less educated and likely in those who
are poorer than the general population (8,9). Alcohol abuse
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has increased among Brazilian men and, more significantly,
among women (10).
The criteria that define smoking and drinking vary widely
among studies. We understand that our criteria are strict,
especially for drinking habits, but they are in accordance
with large international series (11,12) and guarantee purity
of the NSND group. The large majority of the patients in our
study who drink consumed substantially more alcohol than
the limits proposed for our group.
Previous series have shown that 2.4 to 14% of patients
with SCCHN have never smoked or consumed alcohol (13–
16). Long-term series are necessary to achieve a significant
number of NSND patients. GENCAPO encompasses five
Head and Neck Surgery Services from Sa˜o Paulo, the most
Figure 1 - Age, site and gender distributions according to smoking and drinking habits in patients with SCCHN. NSND: Non-smokers/
non-drinkers; SD: smokers/drinkers; SND: smokers-only; NSD: drinkers-only. OC: oral cavity; OP: oropharynx; L: larynx; HP: hypopharynx;
other: other combination of sites.
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populous Brazilian state, which have prospectively enrolled
patients in a standardized manner for several years.
In our study, the NSND patients were most frequently
women – remarkably, elderly women – who presented with
oral cavity cancers. The SD patients were younger than the
other groups, possibly due to the synergistic effect of the
carcinogens from alcohol and tobacco. Some studies have
found the NSND patients to be younger than the SD
patients (17) with oropharynx tumors. Other studies have
found that the NSND patients are older than other patients
and that they have oral cavity tumors (16,18). As the
patients were enrolled primarily in surgery services, we
might have included fewer young patients with orophar-
yngeal cancer because they are at times referred directly and
exclusively to radiation and chemotherapy due to the
traditionally good response to these treatment modalities
in these cases.
The SND patients were more frequently affected by
larynx cancer than the other groups. This finding is
consistent with other studies (11,19), suggesting that the
larynx is more susceptible to the carcinogens from tobacco
than alcohol.
Although differences were observed in regards to
ethnicity, and we believe they exist, this issue is a
controversial subject in Brazilian populations due to intense
miscegenation (20). The NSND patients were more fre-
quently white compared to the SD and SND groups, a
finding which has been reported in other studies (21).
The patients in the smokers group had a lower average
BMI than those in the non-smokers group, which has been
previously observed (22,23). Alcohol is related to malnutri-
tion, but we may have not observed this relationship among
patients in the NSD group due to the small number of
patients in this group. Low BMI has been associated with
Table 1 - Sociodemographic features according to smoking and drinking categories.
Feature NSND N (%) SD N (%) SND N (%) NSD N (%) p-value
Gender ,0.001*
Female 57 (71.3) 96 (7.0) 67 (47.9) 11 (28.2)
Male 23 (28.8) 1278 (93.0) 73 (52.1) 28 (71.8)
Age (y) ,0.001{
Mean (sd) 62.79 (16.30)b{ 57.13 (9.79) a{ 62.21 (11.74) b{ 62.33 (15.12) b{
Ethnicity ,0.001*
White 65 (82.3) 988 (74.0) 106 (76.8) 32 (82.1)
Mulatto 5 (6.3) 242 (18.1) 22 (15.9) 1 (2.6)
Black 4 (5.1) 99 (7.4) 6 (4.3) 5 (12.8)
Asian 4 (5.1) 4 (0.3) 4 (2.9) 1 (2.6)
Indian 1 (1.3) 3 (0.2) 0 0
BMI ,0.001{
Mean (sd) 26.81 (4.89) b{ 23.92 (3.88) a{ 24.58 (4.53) a{ 26.62 (4.06) b{
Smoking 1st degree relatives ,0.001{
Mean (sd) 2.39 (2.38) a{ 4.17 (2.93) b{ 4.44 (3.76) b{ 3.16 (2.52) a, b {
Relatives with cancer/total relatives 0.406{
Mean (sd) 0.08 (0.10) 0.10 (0.14) 0.09 (0.13) 0.10 (0.14)
NSND: Non-smokers/non-drinkers; SD: smokers/drinkers; SND: smokers/non drinkers; NSD: non smokers/drinkers. sd: standard deviation. BMI: body mass
index. *Chi-square test. {Analysis of variance (ANOVA one-way). {Tukey’s test – groups with the same letter are not different (p.0.05).
Table 2 - Clinical features according to smoking and drinking categories.
Feature NSND N (%) SD N (%) SND N (%) NSD N (%) p-value{
Site* ,0.001
Oral cavity 50 (62.5) 493 (35.9) 43 (30.7) 14 (35.9)
Oral cavity + oropharynx 7 (8.8) 114 (8.3) 20 (14.3) 7 (17.9)
Oropharynx 11 (13.8) 241 (17.5) 7 (5.0) 5 (12.8)
Larynx 11 (13.8) 384 (27.9) 62 (44.3) 11 (28.2)
Hypopharynx 1 (1.3) 119 (8.7) 8 (5.7) 2 (5.1)
Other combination of sites 0 23 (1.7) 0 0
cT stage 0.369
1 11 (14.9) 129 (9.8) 14 (10.9) 6 (16.2)
2 24 (32.4) 326 (24.8) 40 (31.0) 8 (21.6)
3 13 (17.6) 310 (23.6) 29 (22.5) 10 (27.0)
4 26 (35.1) 548 (41.7) 46 (35.7) 13 (35.1)
Clinical nodal metastasis ,0.001
No 46 (62.2) 586 (44.6) 84 (65.1) 22 (59.5)
Yes 28 (37.8) 727 (55.4) 45 (34.9) 15 (40.5)
Clinical Stage{ 0.029
0 0 1 (0.1) 0 0
I 10 (13.5) 87 (6.6) 13 (10.1) 3 (8.1)
II 16 (21.6) 199 (15.1) 30 (23.3) 6 (16.2)
III 13 (17.6) 266 (20.2) 29 (22.5) 9 (24.3)
IV 35 (47.3) 763 (58.0) 57 (44.2) 19 (51.4)
NSND: Non-smokers/non-drinkers; SD: smokers/drinkers; SND: smokers/non drinkers; NSD: non smokers/ drinkers. *‘‘other combination of sites’’ excluded
from the analysis. {Clinical Stage =0 excluded from the analysis. { Chi-square test.
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increased mortality among SCCHN patients who smoke
(24).
We attempted to estimate home exposure to tobacco by
comparing the average number of first-degree relatives
who smoke. Measuring environmental lifetime exposure to
tobacco is difficult (25), and data about smoking by a
spouse or workplace exposure were not routinely collec-
ted. Biological samples for urinary or serum cotinine
measurements were not collected. We found that the
NSND patients had fewer first-degree relatives who
smoked and may have had less exposure to environmental
smoking. We do not believe that passive smoking is a major
risk factor for this group, but it would be necessary to
compare environmental smoking in cancer-free patients to
ensure this result. Family cancer history was not different
among the groups.
Table 3 - Pathological features according to smoking and drinking categories.
Feature NSND N (%) SD N (%) SND N (%) NSD N (%) p-value{
pT stage 0.160
0, is 1 (1.4) 12 (1.1) 1 (0.8) 1 (3.0)
1 15 (20.5) 140 (12.3) 15 (12.1) 4 (12.1)
2 26 (35.6) 280 (24.5) 34 (27.4) 8 (24.2)
3 11 (15.1) 196 (17.2) 23 (18.5) 9 (27.3)
4 20 (27.4) 514 (45.0) 51 (41.1) 11 (33.3)
Pathological nodal metastasis 0.006
No 37 (54.4) 473 (42.8) 67 (57.8) 15 (48.4)
Yes 31 (45.6) 631 (57.2) 49 (42.2) 16 (51.6)
Pathological Stage* 0.005
0 0 4 (0.3) 1 (0.8) 0
I 12 (16.2) 99 (8.5) 14 (11.1) 3 (8.6)
II 15 (20.3) 152 (13.0) 21 (16.7) 7 (20.0)
III 11 (14.9) 169 (14.5) 30 (23.8) 7 (20.0)
IV 36 (48.6) 742 (63.6) 60 (47.6) 18 (51.4)
Tumor variants 0.123
Squamous cell carcinoma 70 (94.6) 1151 (95.4) 106 (89.1) 33 (100.0)
Verrucous carcinoma 2 (2.7) 5 (0.4) 2 (1.7) 0
Basaloid 1 (1.4) 24 (2.0) 3 (2.5) 0
Papillary 1 (1.4) 2 (0.2) 1 (0.8) 0
Spindle Cell 0 4 (0.3) 2 (1.7) 0
Solid 0 14 (1.2) 2 (1.7) 0
Other 0 6 3 0
Differentiation 0.005
Well differentiated 42 (55.3) 419 (34.0) 46 (35.9) 16 (45.7)
Moderately differentiated 29 (38.2) 702 (57.0) 70 (54.7) 19 (54.3)
Poorly differentiated 5 (6.6) 110 (8.9) 12 (9.4) 0
Vascular invasion 0.571
Absent 62 (91.2) 934 (85.8) 103 (88.0) 26 (83.9)
Present 6 (8.8) 154 (14.2) 14 (12.0) 5 (16.1)
Lymphatic invasion 0.001
Absent 50 (78.1) 653 (62.2) 86 (77.5) 19 (67.9)
Present 14 (21.9) 396 (37.8) 25 (22.5) 9 (32.1)
Perineural invasion 0.495
Absent 40 (58.8) 626 (57.8) 75 (62.5) 22 (68.8)
Present 28 (41.2) 457 (42.2) 45 (37.5) 10 (31.3)
Peri-tumor inflammatory infiltrate 0.397
Absent 5 (8.5) 100 (10.4) 12 (12.2) 0
Low 21 (35.6) 355 (36.9) 35 (35.7) 8 (38.1)
Moderate 23 (39.0) 428 (44.5) 40 (40.8) 10 (47.6)
Intense 10 (16.9) 79 (8.2) 11 (11.2) 3 (14.3)
NSND: Non-smokers/non-drinkers; SD: smokers/drinkers; SND: smokers/non drinkers; NSD: non smokers/drinkers. *Pathological Stage=0 excluded from
the analysis. {Chi-square test.
Table 4 - Association of significant categorical variables among groups.
Variable NSND/SD p-value* NSND/SND p-value* NSND/NSD p-value* SD/SND p-value* SD/NSD p-value*
SND/NSD
p-value*
Gender ,0.001 0.001 ,0.001 ,0.001 ,0.001 0.029
Ethnicity ,0.001 0.174 0.453 0.001 0.014 0.050
Site ,0.001 ,0.001 0.042 ,0.001 0.324 0.261
cN+ 0.003 0.673 0.783 ,0.001 0.074 0.528
pN+ 0.062 0.658 0.578 0.002 0.539 0.351
Pathological Stage 0.039 0.450 0.699 0.008 0.580 0.928
Differentiation 0.001 0.027 0.125 0.879 0.104 0.137
Lymphatic invasion 0.011 0.921 0.295 0.002 0.545 0.290
NSND: non smokers/non drinkers; SD: smokers/drinkers; SND: smokers/non drinkers; NSD: non smokers/drinkers. cN+: clinical nodal metastasis; pN+:
pathological nodal metastasis; *Chi-square test.
Head & neck cancer according to smoking and drinking
Moyses RA et al.
CLINICS 2013;68(6):738-744
742
The SD patients presented with nodal metastasis and
pathological lymphatic invasion more frequently than the
other groups. Our data suggest that this result may be more
strongly related to alcohol than to tobacco, and patients in
the SD and NSD groups showed nodal metastasis more
frequently than did the patients who did not drink. This
association has been described for other cancer types, but
not for SCCHN (26,27). Further and more specific analysis
of the data, including an analysis of the intensity of
exposure, is being conducted. The underlying mechanism
for this event is unknown, but suppression of the metastatic
suppressor gene and decreased numbers of NK cells in the
peripheral lymph nodes may partially explain these find-
ings (26,27). Tobacco, but not alcohol, has been associated
with neck metastasis for SCCHN (28). Likely as a
consequence of these observations, the SD patients exhibited
different distributions of SCCHN pathological stages,
tending to present at more advanced stages than the
NSND and SND patient. Heavy drinking and heavy
smoking have been associated with diagnostic delays in T
stage and nodal metastasis (29,30). We noted no statistical
differences among the groups in terms of clinical or
pathological T stage.
The tumors in the NSND patients appeared to be
histologically more differentiated than the tumors in the
SND and SD patients. The patients who were smokers
seemed to have less-differentiated tumors than the non-
smokers, suggesting a tobacco-related effect. A similar
association has been reported for bladder cancer (31).
Dahlstrom et al. found that a majority of the NSND patients
presented with well-differentiated (oral cavity) or poorly
differentiated (oropharynx) tumors, whereas the majority of
the smoking/drinking patients presented with moderately
differentiated tumors (17). The differentiation findings of
both studies are likely similar because the NSND patients in
our study typically had oral cavity tumors and few
oropharynx tumors. Other pathological features such as
tumor variants, vascular/perineural invasion and peri-
tumor inflammatory infiltrate, were not different among
the groups.
The exploratory nature of this study may lead to an
increased type I error. Considering an alpha of 0.05, we
would expect the 20 analyses performed (Tables 1–3) to have
one significantly different finding due exclusively to chance.
Regarding the generalizability of these findings, it should
be noted that these subjects belong to a cohort of patients
from the public health services in Sa˜o Paulo. The associa-
tions identified in this study should be validated in other
populations.
We have shown several demographic, clinical and
pathological differences according to smoking and drinking
habits. An important subset of NSND elderly females with
oral cavity cancer was identified, but the risk factors for this
population are unknown. The additional and unexpected
findings from our data were that alcohol may be related to
the nodal metastasis of SCCHN and that tobacco may
predispose patients to less-differentiated tumors. These
findings may help elucidate the possible mechanisms of
the carcinogenesis of alcohol and tobacco. Studies designed
to answer these questions may be necessary to confirm these
hypotheses.
& ACKNOWLEDGMENTS
The authors would like to thank the members of the GENCAPO (Head
and Neck Genome) Project and Fundac¸a˜o de Amparo a` Pesquisa do
Estado de Sa˜o Paulo (FAPESP). This study was supported by FAPESP (04/
12054-9).
& AUTHOR CONTRIBUTIONS
Moyses RA and Michaluart Jr P contributed to the conception, data
collection and analysis, and manuscript elaboration. Lo´pez RVM, Cury
PM and Tajara EH contributed to the conception, data analysis, and
manuscript review. Siqueira SAC, Curioni OA, Gois Filho JF, and
Figueiredo DLA collected the data and participated in the review of the
manuscript. Head and Neck Genome Project GENCAPO (group of
researchers) collected the data and participated in the study conception.
& REFERENCES
1. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide [data-
base on the Internet]. International Agency for Research on Cancer. 2010.
Figure 2 - Distribution of smoking and drinking habits according to tumor site in patients with SCCHN. NSND: Non-smokers/non-
drinkers; SD: smokers/drinkers; SND: smokers/non drinkers; NSD: non smokers/drinkers. p,0.001 (Chi-square test).
CLINICS 2013;68(6):738-744 Head & neck cancer according to smoking and drinking
Moyses RA et al.
743
2. Piccirillo JF, Costas I, Reichman ME. Cancers of the Head and Neck.
SEER Survival Monograph: Cancer Survival Among Adults: US SEER
Program, 1988-2001, Patient and Tumor Characteristics [serial on the
Internet]. 2007: Available from: http://seer.cancer.gov/publications/
survival/surv_head_neck.pdf.
3. Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head
and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010
May 5.
4. Fleming I. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott
- Raven; 1997.
5. Greene F, Page DL, Fleming ID, Fritz AG, Balch AM, Haller DG, Marrow
M. AJCC cancer staging manual. 6th ed. Chicago: Springer; 2002.
6. Carvalho AL, Ikeda MK, Magrin J, Kowalski LP. Trends of oral and
oropharyngeal cancer survival over five decades in 3267 patients treated
in a single institution. Oral Oncol. 2004;40(1):71-6, http://dx.doi.org/10.
1016/S1368-8375(03)00138-6.
7. Bergamasco V, Marta GN, Kowalski LP, Carvalho AL. Epidemiological
profile of the head and neck cancer in the State of Sa˜o Paulo. Rev Bras Cir
Cabec¸a Pescoc¸o. 2008;37(1):15-9.
8. Iglesias R, Jha P, Pinto M, Silva VLC, Godinho J. Controle do Tabagismo
no Brasil 2007: Available from: http://portal.saude.gov.br/portal/
arquivos/pdf/Controle%20do%20Tabagismo%20no%20Brasil.pdf.
9. Boing AF, Ferreira Antunes JL, de Carvalho MB, de Gois Filho JF,
Kowalski LP, Michaluart P Jr., et al. How much do smoking and alcohol
consumption explain socioeconomic inequalities in head and neck cancer
risk? J Epidemiol Community Health. 2011;65(8):709-14, http://dx.doi.
org/10.1136/jech.2009.097691.
10. Secretaria de Vigilaˆncia em Sau´de Secretaria de Gesta˜o Estrate´gica e
Participativa. Vigitel Brazil 2008: protection and risk factors for chronic
diseases by telephone inquiry 2009: Available from: http://portal.saude.
gov.br/portal/arquivos/pdf/VIGITEL2008_web.pdf.
11. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado
MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking
in never drinkers, and the risk of head and neck cancer: pooled analysis
in the International Head and Neck Cancer Epidemiology Consortium.
J Natl Cancer Inst. 2007;99(10):777-89.
12. Szymanska K, Hung RJ, Wunsch-Filho V, Eluf-Neto J, Curado MP,
Koifman S, et al. Alcohol and tobacco, and the risk of cancers of the
upper aerodigestive tract in Latin America: a case-control study. Cancer
Causes Control. 2011;22(7):1037-46, http://dx.doi.org/10.1007/s10552-
011-9779-7.
13. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck
cancer in nonsmokers: a distinct clinical and molecular entity.
Laryngoscope. 1999;109(10):1544-51, http://dx.doi.org/10.1097/00005537-
199910000-00002.
14. Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM. Matched-
pair analysis of survival of never smokers and ever smokers with
squamous cell carcinoma of the head and neck. J Clin Oncol.
2004;22(19):3981-8, http://dx.doi.org/10.1200/JCO.2004.02.133.
15. Farshadpour F, Hordijk GJ, Koole R, Slootweg PJ. Non-smoking and
non-drinking patients with head and neck squamous cell carcinoma: a
distinct population. Oral Dis. 2007;13(2):239-43, http://dx.doi.org/10.
1111/j.1601-0825.2006.01274.x.
16. Wiseman SM, Swede H, Stoler DL, Anderson GR, Rigual NR, Hicks WL,
Jr., et al. Squamous cell carcinoma of the head and neck in nonsmokers
and nondrinkers: an analysis of clinicopathologic characteristics and
treatment outcomes. Ann Surg Oncol. 2003;10(5):551-7, http://dx.doi.
org/10.1245/ASO.2003.09.010.
17. Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM.
Squamous cell carcinoma of the head and neck in never smoker-never
drinkers: a descriptive epidemiologic study. Head Neck. 2008;30(1):75-
84, http://dx.doi.org/10.1002/hed.20664.
18. Farshadpour F, Roepman P, Hordijk GJ, Koole R, Slootweg PJ. A gene
expression profile for non-smoking and non-drinking patients with head
and neck cancer. Oral Dis. 2012;18(2):178-83, http://dx.doi.org/10.1111/
j.1601-0825.2011.01861.x.
19. Schlecht NF, Franco EL, Pintos J, Negassa A, Kowalski LP, Oliveira BV,
et al. Interaction between tobacco and alcohol consumption and the risk
of cancers of the upper aero-digestive tract in Brazil. Am J Epidemiol.
1999;150(11):1129-37.
20. Callegari-Jacques SM, Grattapaglia D, Salzano FM, Salamoni SP,
Crossetti SG, Ferreira ME, et al. Historical genetics: spatiotemporal
analysis of the formation of the Brazilian population. Am J Hum Biol.
2003;15(6):824-34.
21. Harris SL, Kimple RJ, Hayes DN, Couch ME, Rosenman JG. Never-
smokers, never-drinkers: unique clinical subgroup of young patients
with head and neck squamous cell cancers. Head Neck. 2010;32(4):499-
503.
22. Nieto A, Sanchez MJ, Martinez C, Castellsague X, Quintana MJ, Bosch X,
et al. Lifetime body mass index and risk of oral cavity and oropharyngeal
cancer by smoking and drinking habits. Br J Cancer. 2003;89(9):1667-71,
http://dx.doi.org/10.1038/sj.bjc.6601347.
23. Franceschi S, Dal Maso L, Levi F, Conti E, Talamini R, La Vecchia C.
Leanness as early marker of cancer of the oral cavity and pharynx. Ann
Oncol. 2001;12(3):331-6, http://dx.doi.org/10.1023/A:1011191809335.
24. Gaudet MM, Patel AV, Sun J, Hildebrand JS, McCullough ML, Chen AY,
et al. Prospective studies of body mass index with head and neck cancer
incidence and mortality. Cancer Epidemiol Biomarkers Prev.
2012;21(3):497-503, http://dx.doi.org/10.1158/1055-9965.EPI-11-0935.
25. Lee YC, Boffetta P, Sturgis EM, Wei Q, Zhang ZF, Muscat J, et al.
Involuntary smoking and head and neck cancer risk: pooled analysis in
the International Head and Neck Cancer Epidemiology Consortium.
Cancer Epidemiol Biomarkers Prev. 2008;17(8):1974-81, http://dx.doi.
org/10.1158/1055-9965.EPI-08-0047.
26. Wong AW, Paulson QX, Hong J, Stubbins RE, Poh K, Schrader E, et al.
Alcohol promotes breast cancer cell invasion by regulating the Nm23-
ITGA5 pathway. J Exp Clin Cancer Res. 2011;30:75, http://dx.doi.org/
10.1186/1756-9966-30-75.
27. Zhang H, Zhu Z, Meadows GG. Chronic alcohol consumption decreases
the percentage and number of NK cells in the peripheral lymph nodes
and exacerbates B16BL6 melanoma metastasis into the draining lymph
nodes. Cell Immunol. 2011;266(2):172-9, http://dx.doi.org/10.1016/j.
cellimm.2010.10.001.
28. Mansour OI, Snyderman CH, D’Amico F. Association between tobacco
use and metastatic neck disease. Laryngoscope. 2003;113(1):161-6,
http://dx.doi.org/10.1097/00005537-200301000-00030.
29. Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol
and smoking in diagnostic delay of head and neck cancer patients. Acta
Otolaryngol. 2005;125(5):552-6.
30. Albuquerque R, Lopez-Lopez J, Mari-Roig A, Jane-Salas E, Rosello-
Llabres X, Santos JR. Oral tongue squamous cell carcinoma (OTSCC):
alcohol and tobacco consumption versus non-consumption. A study
in a Portuguese population. Braz Dent J. 2011;22(6):517-21.
31. Jiang X, Castelao JE, Yuan JM, Stern MC, Conti DV, Cortessis VK, et al.
Cigarette smoking and subtypes of bladder cancer. Int J Cancer.
2012;130(4):896-901.
Head & neck cancer according to smoking and drinking
Moyses RA et al.
CLINICS 2013;68(6):738-744
744
